A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Pneumococcal Conjugate Vaccine, 7-Valent (Prevenar) 0.5 mL by Intramuscular Injection.

Trial Profile

A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Pneumococcal Conjugate Vaccine, 7-Valent (Prevenar) 0.5 mL by Intramuscular Injection.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Nov 2010

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 15 Nov 2010 Actual patient number (3366) added as reported by ClinicalTrials.gov.
    • 16 Dec 2009 Actual patient number (3468) added as reported by ClinicalTrials.gov.
    • 16 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top